Moving Away from One-Size-Fits-All: Assessing the Use of Pharmacogenetic-Guided Medication Therapy in Pediatric Patients with Chronic Pain
<b>Background/Objectives:</b> Pharmacogenetic (PGx) testing can predict drug efficacy, toxicity, and risk of adverse drug reactions (ADRs). However, PGx-guided prescribing for pediatric chronic pain is underutilized. <b>Methods</b>: We evaluated the rate of deviance from stan...
Saved in:
| Main Authors: | Danielle Ruskin, Klaudia Szczech, Sierra Scodellaro, Naiyi Sun, Iris Cohn |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Children |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9067/12/6/721 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenomic testing implementation: Tertiary care center experience and results of a pilot of 512 patients
by: Dana Bakheet, et al.
Published: (2025-01-01) -
PHARMACOKINETIC AND PHARMACOGENETIC ASPECTS OF PERSONALIZED ANALGETIC THERAPY WITH FENTANIL TTS IN CLINICAL ONCOLOGY
by: O. P. Bobrova, et al.
Published: (2018-07-01) -
Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences
by: Muriel Javier, et al.
Published: (2023-06-01) -
Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study
by: Noelia Pérez-Gómez, et al.
Published: (2025-07-01) -
Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions—A Longitudinal Mixed-Methods Study Exploring the Patient Perspective
by: Anna Bollinger, et al.
Published: (2025-01-01)